-transparent.png){kind=logo}
Beclomethasone dipropionate aerosol, administered intransally, 50 mcg into each nostril four times a day, was compared to placebo aerosol therapy in a three-week, double-blind trial of 30 patients with allergic rhinitis. Evaluation of efficacy, derived from patient scoring on daily diary cards and a weekly evaluation of signs and symptoms by a physician, showed a statistically significant difference in favor of the beclomethasone dipropionate aerosol. The 400 mcg/day dosage did not provide for systemic absorption as determined by measurements of plasma cortisol levels and circulating eosinophils. The only side effects consisted of mild to moderate burning and stinging or drying of the nasal mucosa.
J P Girard, and
M Cuevas, and
E M Heimlich
January 1991,
The Journal of laryngology and otology,
J P Girard, and
M Cuevas, and
E M Heimlich
November 1974,
British medical journal,
J P Girard, and
M Cuevas, and
E M Heimlich
July 1980,
Clinical allergy,
J P Girard, and
M Cuevas, and
E M Heimlich
January 1985,
The Journal of international medical research,
J P Girard, and
M Cuevas, and
E M Heimlich
March 1978,
Monatsschrift fur Kinderheilkunde,
J P Girard, and
M Cuevas, and
E M Heimlich
November 1987,
Ceskoslovenska otolaryngologie,
J P Girard, and
M Cuevas, and
E M Heimlich
September 1989,
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
J P Girard, and
M Cuevas, and
E M Heimlich
September 1976,
Canadian Medical Association journal,
J P Girard, and
M Cuevas, and
E M Heimlich
January 2016,
Expert review of clinical immunology,
J P Girard, and
M Cuevas, and
E M Heimlich
September 1995,
Rhinology,
